JAIME SALVATIERRA: Open Payments
NPI 1316999535 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,605 in 81 payments from 13 companies in 2025. Trend: 2023 $1,707 · 2024 $1,881 · 2025 $1,605
Food & beverage: $1,605
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $813 |
| ABBVIE INC. | 17 | $184 |
| PFIZER INC. | 15 | $171 |
| Ardelyx, Inc. | 14 | $135 |
| Amgen Inc. | 4 | $78 |
| Viatris Specialty LLC | 3 | $55 |
| Novo Nordisk Inc | 3 | $43 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Antares Pharma, Inc. | 1 | $17 |
Products named: FARXIGA, BREZTRI, IBSRELA, NURTEC ODT, VRAYLAR, AIRSUPRA, LINZESS, YUPELRI.
Industry payments across CA — which companies pay providers there.
